Effect of hyoscine butylbromide first stage of labour in multiparus women

African Health Sciences

Volumn 12, Issue 4, 2012, Pages 408-411

  Sekhavat, L ^a   Karbasi, S A ^a   Fallah, R ^a   Mirowliai, M ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical dilatation; First stage of labor; Hyoscine butylbromide; Second stage of labor

Indexed keywords

PLACEBO; SCOPOLAMINE BUTYL BROMIDE;

ABSENCE OF SIDE EFFECTS; ADULT; APGAR SCORE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; IRAN; LABOR; LABOR COMPLICATION; LABOR DURATION; LABOR INDUCTION; LABOR ONSET; LABOR STAGE 1; LABOR STAGE 2; MATERNAL WELFARE; MULTIPARA; NEWBORN; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; UTERINE CERVIX RIPENING;

CERVICAL DILATATION; FIRST STAGE OF LABOR; HYOSCINE BUTYLBROMIDE; SECOND STAGE OF LABOR;

ADMINISTRATION, ORAL; ADULT; APGAR SCORE; BUTYLSCOPOLAMMONIUM BROMIDE; CESAREAN SECTION; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; IRAN; LABOR STAGE, FIRST; LABOR, INDUCED; MATERNAL AGE; PARASYMPATHOLYTICS; PARITY; PREGNANCY; PREGNANCY OUTCOME; SINGLE-BLIND METHOD; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 84873258970     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v12i4.1     Document Type: Article

References (13)

1. O'Driscoll K, Jackson RJ, Gallagher JT. Prevention of prolonged labor. Br Med J 1969; 2: 477-480
2. Hofmeyr GJ. Obstructed labor: using better technologies to reduce mortality. International Journal of Gynecology and Obstetrics 2004; 85 Suppl 1: S62-S72.
3. Tan PC, Jacob R, Omar SZ. Membrane sweeping at initiation of formal labor induction: a randomized controlled trial. Obstet and gynecol 2006; 107(3): 569-77
4. Jenkin G, Young I. Mechanisms responsible for parturition; the use of experimental models. Anim Reprod Sci 2004; 82: 567-81.
5. Sharami SH, Milani F, Zahiri Z, Mansour-Ghanaei F. A randomized trial of prostaglandin E2 gel and extraamniotic saline infusion with high dose oxytocin for cervical ripening. Med Sci Monit 2005; 11(8): CR381-CR386.
6. Rayburn.WF. Preinduction Cervical Ripening: Basis and Methods of Current Practice. Obstetrical & Gynecological Survey 2002; 57(10):683-692.
7. Samuels LA, Christie L, Roberts-Gitten B, Fletcher H, Frederick J. The effect of hyoscine butylbromide on the first stage of labor in term pregnancy. Br J Obstet Gynecol 2007; 114:1542-6.
8. Hotwani J, Ainapure SS. Hyoscine Butylbromide suppositories. Indian Medical Gaz 2000: 217-9.
9. Drug Information: Buscopan®. Ingelheim, Germany: Boehringer Ingelheim Limited. Revised December 2005.
10. Sirohiwal D, Dahiya K, Mandira DE.Efficacy of hyoscine-N-butylbromide (Buscopan) suppositories as a cervical spasmolytic agent in labor. Australian and New Zealand Journal of Obstetrics and Gynaecology 2005; 45 (2): 128-129.
11. Nicholson JM, Kellar LC, Cronholm PF, Macones GA. Active management of risk in pregnancy at term in an urban population: An association between a higher induction of labor rate and a lower cesarean delivery rate. American Journal of Obstetrics & Gynecology 2004; 191(5):1516-1528.
12. Samuels LA, Christie L, Roberts-Gittens B, Fletcher H, Frederick J. The Effect of Hyoscine Butylbromide on the First Stage of Labor in Term Pregnancies. Obstetrical & Gynecological Survey 2008; 63(4):209-210.
13. Al Dohami HS, Al Matari FI. Is Buscopan (hyoscine-N-butylbromide) effective in shortening labor? Presented at: 12th Annual General Meeting of the Saudi Obstetric and Gynaecological Society 2002.